We are live on ! Find out more
CDMO

Avid Bioservices, Inc. Common Stock
CDMO

Delisted

CDMO was delisted on the 4th of February, 2025.

Back to rankings

81 hedge funds and large institutions have $48M invested in Avid Bioservices, Inc. Common Stock in 2018 Q2 according to their latest regulatory filings, with 26 funds opening new positions, 17 increasing their positions, 16 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

86% more first-time investments, than exits

New positions opened: 26 | Existing positions closed: 14

56% more capital invested

Capital invested by funds: $30.8M → $48M (+$17.2M)

16% more funds holding

Funds holding: 70 → 81 (+11)

6% more repeat investments, than reductions

Existing positions increased: 17 | Existing positions reduced: 16

45% less call options, than puts

Call options by funds: $269K | Put options by funds: $491K

Holders
81
Holders Change
+11
Holders Change %
+15.71%
% of All Funds
1.85%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
26
Increased
17
Reduced
16
Closed
14
Calls
$269K
Puts
$491K
Net Calls
-$222K
Net Calls Change
-$329K

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$8.68M
2
State Street
State Street
Massachusetts
+$2.3M
3
Northern Trust
Northern Trust
Illinois
+$1.57M
4
Vanguard Group
Vanguard Group
Pennsylvania
+$868K
5
Geode Capital Management
Geode Capital Management
Massachusetts
+$836K

Top Sellers

Rank Fund Capital Flow
1
KCM
Kennedy Capital Management
Missouri
-$6.67M
2
CH
CVI Holdings
Delaware
-$1.73M
3
Renaissance Technologies
Renaissance Technologies
New York
-$767K
4
Millennium Management
Millennium Management
New York
-$480K
5
UOC
UBS O'Connor
Illinois
-$441K
Name Holding Trade Value Shares
Change 		Change in
Stake
AIP
51
Ameritas Investment Partners
Nebraska
$18K +$16.3K +4,695 New
Bank of America
52
Bank of America
North Carolina
$17K -$34.3K -9,900 -70%
Barclays
53
Barclays
United Kingdom
$15K +$12.9K +3,720 New
AG
54
Advisor Group
Arizona
$12K -$1.39K -400 -11%
IA
55
IFP Advisors
Florida
$12K – – –
GWM
56
Geneos Wealth Management
Colorado
$10K – – –
SF
57
Synovus Financial
Georgia
$8K – – –
BNP Paribas Financial Markets
58
BNP Paribas Financial Markets
France
$6.5K +$5.75K +1,657 New
RE
59
RBC Europe
United Kingdom
$6.18K +$5.08K +1,465 +1,308%
MAM
60
Meeder Asset Management
Ohio
$5.27K +$4.66K +1,344 New
OIA
61
OneDigital Investment Advisors
Kansas
$5K – – –
Royal Bank of Canada
62
Royal Bank of Canada
Ontario, Canada
$5K – – –
SEI Investments
63
SEI Investments
Pennsylvania
$4K – – –
AF
64
Allworth Financial
California
$3K – – –
BWA
65
BDO Wealth Advisors
Florida
$3K – – –
LTFS
66
Ladenburg Thalmann Financial Services
Florida
$3K – – –
MSA
67
Marino Stram & Associates
Massachusetts
$3K – – –
PIA
68
Piedmont Investment Advisors
North Carolina
$3K +$3.05K +880 New
FGAM
69
Financial Gravity Asset Management
Texas
$1K -$10 -3 -2%
BAM
70
Bruderman Asset Management
New York
$1K – – –
PNC Financial Services Group
71
PNC Financial Services Group
Pennsylvania
$1K – – –
CHP
72
Cable Hill Partners
Oregon
$1K +$867 +250 New
Bank of Montreal
73
Bank of Montreal
Ontario, Canada
$1K +$1.25K +360 New
FDCDDQ
74
Federation des caisses Desjardins du Quebec
Quebec, Canada
$635 – – –
CH
75
CVI Holdings
Delaware
– -$1.73M -591,991 Closed
1 2
3
4

CDMO Hedge Fund Activity: Q2 2018 in Review

81 of the 4,368 institutional investors tracked by Wall St. Rank reported a position in Avid Bioservices, Inc. Common Stock (CDMO) for Q2 2018, worth a combined $48M — up 56% from $30.8M a quarter earlier.

Buyers outnumbered sellers: 26 funds opened new CDMO positions and 14 closed out — a net gain of 12 holders — while 17 added to existing stakes and 16 trimmed.

The largest buyer was BlackRock, adding an estimated $8.68M. The largest seller was Kennedy Capital Management, cutting an estimated $6.67M.

  • 81 institutional investors held Avid Bioservices, Inc. Common Stock (CDMO) as of Q2 2018, up from 70 in Q1 2018.
  • Funds reported $48M of Avid Bioservices, Inc. Common Stock stock for Q2 2018, up 56% quarter-over-quarter.
  • 26 funds opened new Avid Bioservices, Inc. Common Stock positions in Q2 2018 and 14 closed out, a net change of +12 holders.
  • The largest Avid Bioservices, Inc. Common Stock buyer in Q2 2018 was BlackRock, an estimated $8.68M added.
  • The largest Avid Bioservices, Inc. Common Stock seller in Q2 2018 was Kennedy Capital Management, an estimated $6.67M sold.

Based on aggregated 13F filings for Q2 2018.